ArticleCell biology international2026

Sotagliflozin, a Dual SGLT1/2 Inhibitor, Modulates DNMT1 and Class I/II HDAC Expression in Association With Anticancer Effects in Breast and Lung Cancer Cells.

P K Hima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.